Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


10.04.2017

1 BMC Neurol
1 Brain
2 Intern Med
10 J Autoimmun
1 J Clin Endocrinol Metab
1 J Immunol
6 J Neuroimmunol
13 J Neurol
3 J Rheumatol
2 Lancet
7 Mult Scler
1 Nat Rev Neurol
1 Proc Natl Acad Sci U S A
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. HOLMOY T, Lindstrom JC, Eriksen EF, Steffensen LH, et al
    High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
    BMC Neurol. 2017;17:67.
    PubMed     Text format     Abstract available


    Brain

  2. JURYNCZYK M, Geraldes R, Probert F, Woodhall MR, et al
    Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Brain. 2017;140:617-627.
    PubMed     Text format     Abstract available


    Intern Med

  3. MASUDA H, Mori M, Iwai Y, Kuwabara S, et al
    Severe Subcutaneous Calcification in an Interferon-beta-treated MS Patient.
    Intern Med. 2017;56:879-880.
    PubMed     Text format    

  4. TAKEHARA E, Mandai S, Shikuma S, Akita W, et al
    Post-infectious Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits Associated with Complement Factor H Mutation.
    Intern Med. 2017;56:811-817.
    PubMed     Text format     Abstract available


    J Autoimmun

  5. WILCOX NS, Rui J, Hebrok M, Herold KC, et al
    Life and death of beta cells in Type 1 diabetes: A comprehensive review.
    J Autoimmun. 2016 Mar 23. pii: S0896-8411(16)30003.
    PubMed     Text format     Abstract available

  6. PAUN A, Yau C, Danska JS
    Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    J Autoimmun. 2016 Feb 20. pii: S0896-8411(16)30006.
    PubMed     Text format     Abstract available

  7. BUCKNER JH, Nepom GT
    Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.
    J Autoimmun. 2016 Mar 3. pii: S0896-8411(16)30011.
    PubMed     Text format     Abstract available

  8. TAI N, Wong FS, Wen L
    The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
    J Autoimmun. 2016 Mar 24. pii: S0896-8411(16)30019.
    PubMed     Text format     Abstract available

  9. EHLERS MR
    Strategies for clinical trials in type 1 diabetes.
    J Autoimmun. 2016 Apr 5. pii: S0896-8411(16)30021.
    PubMed     Text format     Abstract available

  10. MESSINA N, Fulford T, O'Reilly L, Loh WX, et al
    The NF-kappaB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells.
    J Autoimmun. 2016;70:52-62.
    PubMed     Text format     Abstract available

  11. KRISHNAMURTHY B, Selck C, Chee J, Jhala G, et al
    Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    J Autoimmun. 2016 Apr 12. pii: S0896-8411(16)30031.
    PubMed     Text format     Abstract available

  12. BRAUDEAU C, Amouriaux K, Neel A, Herbreteau G, et al
    Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.
    J Autoimmun. 2016;70:73-9.
    PubMed     Text format     Abstract available

  13. GITELMAN SE, Bluestone JA
    Regulatory T cell therapy for type 1 diabetes: May the force be with you.
    J Autoimmun. 2016 Apr 28. pii: S0896-8411(16)30024.
    PubMed     Text format     Abstract available

  14. SAUNDERS D, Powers AC
    Replicative capacity of beta-cells and type 1 diabetes.
    J Autoimmun. 2016 Apr 28. pii: S0896-8411(16)30027.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  15. JONSDOTTIR B, Larsson C, Carlsson A, Forsander G, et al
    Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis.
    J Clin Endocrinol Metab. 2017;102:1277-1285.
    PubMed     Text format     Abstract available


    J Immunol

  16. WATANABE T, Yamashita K, Arai Y, Minaga K, et al
    Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-alpha and IL-33 Produced by Plasmacytoid Dendritic Cells.
    J Immunol. 2017 Apr 3. pii: 1700060. doi: 10.4049/jimmunol.1700060.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  17. SELMAJ I, Mycko MP, Raine CS, Selmaj KW, et al
    The role of exosomes in CNS inflammation and their involvement in multiple sclerosis.
    J Neuroimmunol. 2017;306:1-10.
    PubMed     Text format     Abstract available

  18. RAMAKRISHNAN V, Akram Husain RS, Ahmed SS
    Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis.
    J Neuroimmunol. 2017;306:11-18.
    PubMed     Text format     Abstract available

  19. BERMUDEZ-MORALES VH, Fierros G, Lopez RL, Martinez-Nava G, et al
    Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults.
    J Neuroimmunol. 2017;306:20-24.
    PubMed     Text format     Abstract available

  20. CONSTANTINESCU R, Krysl D, Andren K, Asztely F, et al
    Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.
    J Neuroimmunol. 2017;306:25-30.
    PubMed     Text format     Abstract available

  21. SISAY S, Lopez-Lozano L, Mickunas M, Quiroga-Fernandez A, et al
    Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    J Neuroimmunol. 2017;306:40-45.
    PubMed     Text format     Abstract available

  22. AKAISHI T, Nakashima I, Mugikura S, Aoki M, et al
    Whole brain and grey matter volume of Japanese patients with multiple sclerosis.
    J Neuroimmunol. 2017;306:68-75.
    PubMed     Text format     Abstract available


    J Neurol

  23. HONG Y, Skeie GO, Zisimopoulou P, Karagiorgou K, et al
    Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
    J Neurol. 2017 Mar 31. doi: 10.1007/s00415-017-8478.
    PubMed     Text format     Abstract available

  24. ABSINTA M, Reich DS, Filippi M
    Spring cleaning: time to rethink imaging research lines in MS?
    J Neurol. 2016;263:1893-902.
    PubMed     Text format     Abstract available

  25. VINJAM MR, Shanmugarajah P, Ford HL
    Ophthalmoplegia heralding the onset of anti-amphiphysin related paraneoplastic stiff person syndrome.
    J Neurol. 2016;263:1017-8.
    PubMed     Text format    

  26. GRIMM A, Vittore D, Schubert V, Rasenack M, et al
    Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
    J Neurol. 2016;263:1074-82.
    PubMed     Text format     Abstract available

  27. BRIER MR, Day GS, Snyder AZ, Tanenbaum AB, et al
    N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI.
    J Neurol. 2016;263:1083-91.
    PubMed     Text format     Abstract available

  28. HAVRDOVA E, Belova A, Goloborodko A, Tisserant A, et al
    Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
    J Neurol. 2016;263:1287-95.
    PubMed     Text format     Abstract available

  29. BALK LJ, Cruz-Herranz A, Albrecht P, Arnow S, et al
    Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
    J Neurol. 2016;263:1323-31.
    PubMed     Text format     Abstract available

  30. JEONG IH, Kim HJ, Kim NH, Jeong KS, et al
    Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
    J Neurol. 2016;263:1343-8.
    PubMed     Text format     Abstract available

  31. GIORLI E, Franciotta D, Beronio A, Amodeo C, et al
    Late AQP4-IgG seroconversion and shrinking of brainstem MRI lesions in a patient with overlapping CIS/NMOSD.
    J Neurol. 2016;263:2549-2551.
    PubMed     Text format    

  32. HUSS AM, Halbgebauer S, Ockl P, Trebst C, et al
    Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
    J Neurol. 2016;263:2499-2504.
    PubMed     Text format     Abstract available

  33. HUANG Q, Wu Y, Qin R, Wei X, et al
    Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.
    J Neurol. 2016;263:2446-2455.
    PubMed     Text format     Abstract available

  34. PIETRZAK K, Grzybowski A, Kaczmarczyk J
    Georges Guillain (1876-1961).
    J Neurol. 2016;263:2148-9.
    PubMed     Text format    

  35. ZHOU H, Zhao S, Yin D, Chen X, et al
    Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
    J Neurol. 2016;263:1382-9.
    PubMed     Text format     Abstract available


    J Rheumatol

  36. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Text format     Abstract available

  37. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Text format     Abstract available

  38. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Text format     Abstract available


    Lancet

  39. FELLSTROM BC, Barratt J, Cook H, Coppo R, et al
    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30550.
    PubMed     Text format     Abstract available

  40. WYATT RJ
    Are we ready for targeted therapy for IgA nephropathy?
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30820.
    PubMed     Text format    


    Mult Scler

  41. GIOVANNONI G, Tomic D, Bright JR, Havrdova E, et al
    "No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis.
    Mult Scler. 2017 Apr 1:1352458517703193. doi: 10.1177/1352458517703193.
    PubMed     Text format     Abstract available

  42. AL-LOUZI O, Button J, Newsome SD, Calabresi PA, et al
    Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series.
    Mult Scler. 2017 Apr 1:1352458516679035. doi: 10.1177/1352458516679035.
    PubMed     Text format     Abstract available

  43. SIGNORI A, Izquierdo G, Lugaresi A, Hupperts R, et al
    Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
    Mult Scler. 2017 Apr 1:1352458517703800. doi: 10.1177/1352458517703800.
    PubMed     Text format     Abstract available

  44. SOLARI A, Giordano A, Patti F, Grasso MG, et al
    Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis.
    Mult Scler. 2017 Apr 1:1352458517704078. doi: 10.1177/1352458517704078.
    PubMed     Text format     Abstract available

  45. COHEN JA, Imrey PB, Planchon SM, Bermel RA, et al
    Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.
    Mult Scler. 2017 Apr 1:1352458517703802. doi: 10.1177/1352458517703802.
    PubMed     Text format     Abstract available

  46. INEICHEN BV, Schneider MP, Hlavica M, Hagenbuch N, et al
    High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Mult Scler. 2017 Mar 1:1352458517703801. doi: 10.1177/1352458517703801.
    PubMed     Text format     Abstract available

  47. GYLLENSTEN H, Wiberg M, Alexanderson K, Friberg E, et al
    Comparing costs of illness of multiple sclerosis in three different years: A population-based study.
    Mult Scler. 2017 Mar 1:1352458517702549. doi: 10.1177/1352458517702549.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  48. RIDLER C
    Multiple sclerosis: Adiposity is associated with increased disability rates after a demyelinating event.
    Nat Rev Neurol. 2017 Apr 7. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  49. SCHAMPEL A, Volovitch O, Koeniger T, Scholz CJ, et al
    Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.
    Proc Natl Acad Sci U S A. 2017 Apr 5. pii: 201620052.
    PubMed     Text format     Abstract available


    Thyroid

  50. LI C, Peng S, Liu X, Han C, et al
    Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling.
    Thyroid. 2017 Mar 31. doi: 10.1089/thy.2016.0432.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: